Lineage Cell Therapeutics (LCTX) Change in Account Payables (2017)
Lineage Cell Therapeutics' (LCTX) quarterly Change in Account Payables came in at $428000.0 in Q3 2017, up 323.76% quarter-over-quarter from $101000.0 in Q2 2017.
Lineage Cell Therapeutics (LCTX) Change in Account Payables (2017) Analysis & Trends
Lineage Cell Therapeutics' Change in Account Payables history runs 1 years deep, the most recent figure standing at $428000.0 for Q3 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -42.19 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.52 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 35.60 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.86 Mn |
| 10 | Lineage Cell Therapeutics | 267.08 Mn | 203.18 Mn | 1.73 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2017 | 428,000.00 |
| Sep 30, 2017 | 428,000.00 |
| Jun 30, 2017 | 101,000.00 |
| Jun 30, 2017 | 101,000.00 |
| Mar 31, 2017 | 231,000.00 |
| Mar 31, 2017 | 231,000.00 |